Combination Chemotherapy for Metastatic Brain Tumors-Reference-Cited by-同舟云学术

Combination Chemotherapy for Metastatic Brain Tumors

Published:1981-12 Issue:6 Volume:67 Page:559-562
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori

Author:

Conte Pier Franco¹,Giaccone Giuseppe²,Musella Roberto²,Calciati Alessandro²

Affiliation:

1. Istituto Scientifico per lo Studio e la Cura dei Tumori, Genova

2. Istituto di Oncologia di Torino, Torino

Abstract

Forty-four patients with central nervous system metastases were treated with combination chemotherapy (adriamycin, VM 26 and CCNU). The best results were obtained in breast adenocarcinoma and small cell lung carcinoma with multiple, small cerebral metastases and without concomitant visceral involvement at other sites. The potential effectiveness of this regimen to prevent cerebral metastases is discussed.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030089168106700608

Reference12 articles.

1. Metastatic carcinoma in the central nervous system and dorsal root ganglia.A prospective autopsy study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The аntitumor effect of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) on the growth of spontaneous mammary tumors in HER-2/neu transgenic mice;Siberian journal of oncology;2023-06-29

2. Comparison of clinical neurological function and CT response during chemotherapy for initial brain metastases from small cell lung cancer;Acta Neurologica Scandinavica;2009-01-29

3. Treatment of Brain Metastases in Patients with Small-Cell Lung Cancer: Lessons from Treatment of Other Tumors;Clinical Lung Cancer;2000-08

4. Chemotherapy of Cerebral Metastases from Solid Tumors;Neurosurgery Clinics of North America;1996-07

5. Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen;Annals of Oncology;1993-08